The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 08, 2022

Filed:

Dec. 14, 2016
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Anna P. Tretiakova, Philadelphia, PA (US);

Jenny Agnes Sidrane, Phoenixville, PA (US);

James M. Wilson, Philadelphia, PA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/63 (2006.01); A61K 48/00 (2006.01); C12N 9/10 (2006.01); A61P 1/16 (2006.01); A61K 35/761 (2015.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0058 (2013.01); A61K 35/761 (2013.01); A61K 48/0008 (2013.01); A61P 1/16 (2018.01); C12N 9/1051 (2013.01); C12N 15/62 (2013.01); C12Y 204/01017 (2013.01); C12N 2750/14143 (2013.01); C12N 2810/6027 (2013.01); C12N 2830/008 (2013.01);
Abstract

The invention provides a polynucleotide sequence (e.g., a gene, e.g., DNA or RNA) encoding UGT1A1 (e.g., expressing human UGT1A1). The invention further provides a vector, such as an adeno-associated virus (AAV) vector (e.g., AAV8) having a vector genome including inverted terminal repeat sequences and a UGT1A1 coding sequence operably linked to one or more expression control sequences (e.g., expression control sequences including a liver-specific promoter). Also provided are compositions containing these AAV vectors and methods of treating Crigler-Nijjar syndrome type I, Crigler-Nijjar syndrome type II, and Gilbert syndrome.


Find Patent Forward Citations

Loading…